Since the beginning of February, we have been testing a range of substances that pose a particular health risk. In addition to some high to very high doses of ecstasy tablets, we have tested the new psychoactive substance 4-Methylpentedrone (4-MPD) were identified in an MDMA sample. Furthermore, the new psychoactive substances Methoxphenidine and 3-Methylmethcathinone (3-MMC) was identified in a substance submitted for analysis as ketamine.

The following link lists all samples that have been submitted to us in the period from 1 February 2017 to date. checkit! analysed and classified as high-dose, unexpected or of particular health concern.

Current warnings February 2017